InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by BENEVICH ERIC, Directeur Commercial. Officer active across 1 companies, notably Neurocrine Biosciences INC. Aggregated, 6 reports have been published. Total volume traded: €970k. The latest transaction was filed on 28 November 2025 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
US$398,06712,830 shares@ US$31.02630.0028% mcap45.1% of flow
Common Stock
SEC:0001643653-26-000005·
€398,06712,830 shares@ €31.02630.0028% mcap22.5% of flow
Common Stock
SEC:0001643653-26-000005:0·
€56,978809 shares@ €70.43010.0004% mcap6.5% of flow
Common Stock
SEC:0001209191-22-008204·
€56,978809 shares@ €70.43010.0004% mcap3.2% of flow
Common Stock
SEC:0001209191-22-008204:0·
€428,1815,628 shares@ €76.08050.0030% mcap48.5% of flow
Common Stock
SEC:0001209191-21-052337·
€428,1815,628 shares@ €76.08050.0030% mcap24.2% of flow
Common Stock
SEC:0001209191-21-052337:0·
6 of 6 declarations
About BENEVICH ERIC
Eric Benevich serves as Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC. He is responsible for the company's commercial strategy and business development. Eric brings expertise in sales management and business strategy, enabling him to drive growth initiatives. His role is essential for achieving Neurocrine's performance objectives.
